About this trial
The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM).
The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.
Eligibility criteria
Qualifiers
English-speaking
Adults of any sex
Age range: 18-44 years
Any ethnic/racial background
Disqualifiers
Currently pregnancy
Any sham or active photobiomodulation treatment within the past five weeks.
Trial design
Treatments tested in this trial
- Active transcranial photobiomodulation
- Sham transcranial photobiomodulation
Treatment groups
Sponsors and collaborators
Francisco Gonzalez-Lima, PhD
Lead sponsor
University of Texas at Austin
Sponsor institution